Characterization of hK4 (prostase), a prostate-specific serine protease: activation of the precursor of prostate specific antigen (pro-PSA) and single-chain urokinase-type plasminogen activator and degradation of prostatic acid phosphatase - Wikidata - wikimedia - TriplyDB

Characterization of hK4 (prostase), a prostate-specific serine protease: activation of the precursor of prostate specific antigen (pro-PSA) and single-chain urokinase-type plasminogen activator and degradation of prostatic acid phosphatase

Characterization of hK4 (prostase), a prostate-specific serine protease: activation of the precursor of prostate specific antigen (pro-PSA) and single-chain urokinase-type plasminogen activator and degradation of prostatic acid phosphatase

http://www.wikidata.org/entity/Q28209506

about

sameAs

Twenty Years of PSA: From Prostate Antigen to Tumor Marker Specificity profiling of seven human tissue kallikreins reveals individual subsite preferences Human kallikrein-related peptidase 14 (KLK14) is a new activator component of the KLK proteolytic cascade. Possible function in seminal plasma and skin The emerging roles of human tissue kallikreins in cancer Human tissue kallikrein 5 is a member of a proteolytic cascade pathway involved in seminal clot liquefaction and potentially in prostate cancer progression Hypomaturation enamel defects in Klk4 knockout/LacZ knockin mice Dental enamel development: proteinases and their enamel matrix substrates Direct and indirect mechanisms of KLK4 inhibition revealed by structure and dynamics.Defining the extended substrate specificity of kallikrein 1-related peptidases.Optimization of peptide-based inhibitors of prostate-specific antigen (PSA) as targeted imaging agents for prostate cancer Kallikrein-related peptidase 4: a new activator of the aberrantly expressed protease-activated receptor 1 in colon cancer cells Enzyme-triggered gelation: targeting proteases with internal cleavage sites Surface integrity governs the proteome of hypomineralized enamel.Non-combinatorial library screening reveals subsite cooperativity and identifies new high-efficiency substrates for kallikrein-related peptidase 14.Natural and synthetic inhibitors of kallikrein-related peptidases (KLKs).Activation and enzymatic characterization of recombinant human kallikrein 8.Paclitaxel resistance and multicellular spheroid formation are induced by kallikrein-related peptidase 4 in serous ovarian cancer cells in an ascites mimicking microenvironment.Enzymatic properties of human kallikrein-related peptidase 12 (KLK12).Human tissue kallikreins: a new enzymatic cascade pathway?Enzymatically active prostate-specific antigen promotes growth of human prostate cancers.The role of prostate-specific antigen in the clinical evaluation of prostatic disease.Expression of kallikrein-related peptidase 4 in dental and non-dental tissues.Protease-activated drug development.The tissue kallikrein family of serine proteases: functional roles in human disease and potential as clinical biomarkers.Clinical significance of kallikrein-related peptidase-4 in oral cancer Toward an integrative analysis of the tumor microenvironment in ovarian epithelial carcinoma.Prostate-specific antigen (PSA) is activated by KLK2 in prostate cancer ex vivo models and in prostate-targeted PSA/KLK2 double transgenic mice.Evolution of kallikrein-related peptidases in mammals and identification of a genetic locus encoding potential regulatory inhibitors.The kallikrein world: an update on the human tissue kallikreins.Proteinase-mediated cell signalling: targeting proteinase-activated receptors (PARs) by kallikreins and more.Recombinant kallikrein expression: site-specific integration for hK6 production in human cells.The role of kallikrein-related peptidases in prostate cancer: potential involvement in an epithelial to mesenchymal transition.Prediction of ovarian cancer prognosis and response to chemotherapy by a serum-based multiparametric biomarker panel.Activation profiles of human kallikrein-related peptidases by proteases of the thrombostasis axis Prostatic trypsin-like kallikrein-related peptidases (KLKs) and other prostate-expressed tryptic proteinases as regulators of signalling via proteinase-activated receptors (PARs).New insights into the functional mechanisms and clinical applications of the kallikrein-related peptidase family.Metastasis of ovarian cancer is mediated by kallikrein related peptidases.Functional intersection of the kallikrein-related peptidases (KLKs) and thrombostasis axis.Kallikrein-related peptidases: bridges between immune functions and extracellular matrix degradation.Natural and engineered kallikrein inhibitors: an emerging pharmacopoeia.

P2860

Q24564782-FF794F8A-496C-41A3-9FBF-6D77270B7D64 Q28243373-B561E2A0-6D9F-44B5-8DC7-904A2A77DBB8 Q28259758-E467077C-544D-4F67-A463-BF49E77D651E Q28290701-D75831AC-D7E7-4A74-BF8D-AA86AE002602 Q28300449-D20782DA-EE1B-4824-AC84-E729369F5045 Q28509062-BB9D724B-C757-4484-B40F-F2858CE93E45 Q28677179-D88E9001-09BF-4278-A78A-E05766FA0986 Q30825171-87CD6161-C482-4604-86F2-82377D23ABAD Q33304675-DF57ECC3-816B-419A-A4EF-65606C6E808E Q33471057-C9CA5F92-18D1-46EC-A915-B4DB57554C21 Q33703798-FE94F39E-BDB3-442E-94DC-B0D642B585B9 Q34086670-5D6DAB8F-873A-4FA6-9561-46D3881C9C27 Q34127447-A600A24C-DC28-4586-B6BB-96C83CC3CCEC Q34233325-39F444F4-65EF-456D-A5D6-107149B88AA4 Q34457491-A62C89B3-6C08-4DEA-9BC8-A297334BDA0F Q34541917-4D8F160F-DD21-437C-92E9-5C0653EAE621 Q34602948-12A175E6-AA23-454E-BCF5-83334C50CBB1 Q34613040-CE37ABF6-09F9-458C-B732-0CDDC5FD6030 Q35000702-16D03E9D-23AB-4317-B778-8D5ECD2D1ADC Q35048230-0508FB8E-E801-4C70-A82A-78E69A434FF8 Q35685854-4D920CF9-027A-4676-9B1F-362F0303FA06 Q35727395-C980C5AA-10FC-4718-9209-0AA35A50D9EC Q35811508-88FD079C-1CB3-4D44-AB17-391F265B4A9C Q35861497-D457AA9F-C5F9-49C0-9833-205146EFE6C9 Q36079284-60123320-56D3-4894-BA11-39D6CA1270FE Q36101228-6BBAE6F3-A854-4EAB-8CAA-3A3DB8E5E914 Q36266738-5AFF975F-3E44-49E7-BF13-060EDA6C6502 Q36423144-8D30151B-4D78-427F-B6F5-961AACECFF6F Q36519354-C4AFC6DB-E94F-4B15-A230-79C182470CCC Q36519368-2089011F-AB13-4C13-BBBB-6B5E3263F14B Q36519374-FDA16ED9-8D81-4917-BEC4-7144A22AB4D4 Q36519383-C4AA047E-2EE1-4FEF-9633-86285FC17547 Q36936018-8A525B3F-3B86-409D-BD58-F143D5CA5C5C Q36962704-D2E0B449-76E4-4093-A9B8-4ED25C49299C Q37216570-ECF1A6CD-CDD7-4F14-B646-CE91D3DB6C2A Q37453804-F41C29E9-89E7-4302-BC4C-036413E0DFD4 Q37480184-AD8B89C6-3B63-46A2-9D4E-EE15BE92D62D Q37686524-92391F12-CFE9-45F6-B227-7FE320F775CB Q37697808-B603C2AA-755D-494A-83BB-DD56A8CB5EE9 Q37697810-C98602CF-6764-4341-9E41-BA1924C49CC9

P2860

Characterization of hK4 (prostase), a prostate-specific serine protease: activation of the precursor of prostate specific antigen (pro-PSA) and single-chain urokinase-type plasminogen activator and degradation of prostatic acid phosphatase

http://www.wikidata.org/entity/Q28209506

description

2001 nî lūn-bûn

@nan

2001 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2001 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

name

Characterization of hK4 (prost ...... of prostatic acid phosphatase

@ast

Characterization of hK4 (prost ...... of prostatic acid phosphatase

@en

Characterization of hK4 (prost ...... of prostatic acid phosphatase

@nl

type

label

Characterization of hK4 (prost ...... of prostatic acid phosphatase

@ast

Characterization of hK4 (prost ...... of prostatic acid phosphatase

@en

Characterization of hK4 (prost ...... of prostatic acid phosphatase

@nl

prefLabel

Characterization of hK4 (prost ...... of prostatic acid phosphatase

@ast

Characterization of hK4 (prost ...... of prostatic acid phosphatase

@en

Characterization of hK4 (prost ...... of prostatic acid phosphatase

@nl

P1433

Q28209506-5AD1706B-DFC7-4698-BCDE-48BA8C3E3483

P1476

Q28209506-BD11FF6C-581D-4093-9AFC-97C23E51AC11

P2093

Q28209506-47B63D1E-9C99-4A8F-A9D6-980E0149D687

Q28209506-53001AD3-5EB9-45EF-9A33-8BEA47648BE9

Q28209506-769B0230-FF64-40AA-924B-4CD1A93A0733

Q28209506-8D7510FF-5107-4EEC-9914-9BB525093C06

Q28209506-99512CBA-BD69-4A3A-96B6-1C00E2617802

P304

Q28209506-E1A67895-6561-4833-A3D5-23977B014E13

P31

Q28209506-3218FE33-965D-4534-80F5-789582878D7C

P3181

Q28209506-CBCBCDE7-E822-4A59-B99C-F268EE21E9DD

P356

Q28209506-7D6E9B2C-028F-4336-8031-8EE8E9687962

P407

Q28209506-ED3561AB-7313-4920-92D7-6085BD93257E

P433

Q28209506-4562212F-D078-4117-9931-D5001B1559DC

P478

Q28209506-30ACF59B-53A2-49CB-B476-3688340E7FC2

P577

Q28209506-4A405DAF-6008-42D6-9413-491127B14D43

P698

Q28209506-2476843D-FA35-4AE3-9FF6-0B4AAB14C600

P3181

P356

P1433

P1476

Characterization of hK4 (prost ...... of prostatic acid phosphatase

@en

P2093

B A McMullen

http://www.w3.org/2001/XMLSchema#string

K Fujikawa

http://www.w3.org/2001/XMLSchema#string

M Matsumura

http://www.w3.org/2001/XMLSchema#string

P S Nelson

http://www.w3.org/2001/XMLSchema#string

T K Takayama

http://www.w3.org/2001/XMLSchema#string

P304

15341-8

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2869736

http://www.w3.org/2001/XMLSchema#string

P356

10.1021/BI015775E

http://www.w3.org/2001/XMLSchema#string

P407

P433

50

http://www.w3.org/2001/XMLSchema#string

P478

40

http://www.w3.org/2001/XMLSchema#string

P577

2001-12-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11735417

http://www.w3.org/2001/XMLSchema#string